Medscape

Onset of Efficacy and Tolerability Following the Initiation Dosing of Long-acting Paliperidone Palmitate

Background: Paliperidone palmitate is a long-acting injectable atypical antipsychotic for the acute and maintenance treatment of adults with schizophrenia. The recommended initiation dosing regimen is ...
Monthly Prescribing Reference

Erzofri Approved for Schizophrenia, Schizoaffective Disorder

Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection. The Food and Drug Administration (FDA) has approved Erzofri ® (paliperidone palmitate) ...
Medical News Today

Invega Sustenna side effects and how to manage them

As with other drugs, Invega Sustenna (paliperidone palmitate) can cause side effects, such as excessive sleepiness and injection site reactions. If side effects of Invega Sustenna become difficult to ...
FiercePharma

Study Published in The Journal of Clinical Psychiatry Shows INVEGA SUSTENNA® Effective Six Months Longer Than Common Oral Antipsychotics in Treatment of Schizophrenia

Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study published ...
Healthline

Invega Sustenna Side Effects and Tips for Managing Them

Invega Sustenna (paliperidone palmitate) can cause side effects that range from mild to serious. More common side effects include injection site reactions. If side effects become difficult to tolerate ...